Robert J. Straka

3.6k total citations
109 papers, 2.6k citations indexed

About

Robert J. Straka is a scholar working on Genetics, Surgery and Molecular Biology. According to data from OpenAlex, Robert J. Straka has authored 109 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 27 papers in Surgery and 26 papers in Molecular Biology. Recurrent topics in Robert J. Straka's work include Genetic Associations and Epidemiology (24 papers), Pharmacogenetics and Drug Metabolism (18 papers) and Lipoproteins and Cardiovascular Health (17 papers). Robert J. Straka is often cited by papers focused on Genetic Associations and Epidemiology (24 papers), Pharmacogenetics and Drug Metabolism (18 papers) and Lipoproteins and Cardiovascular Health (17 papers). Robert J. Straka collaborates with scholars based in United States, Spain and Canada. Robert J. Straka's co-authors include Donna K. Arnett, José M. Ordovás, Michael Y. Tsai, Chao‐Qiang Lai, James E. Hixson, Michael A. Province, Patrick Caron, Edmond K. Kabagambe, Olivier Barbier and Laurence D. Parnell and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Diabetes Care.

In The Last Decade

Robert J. Straka

108 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Straka United States 30 709 542 505 439 437 109 2.6k
Stephan Krähenbühl Switzerland 32 988 1.4× 446 0.8× 344 0.7× 194 0.4× 347 0.8× 100 3.1k
Dimitrinka Nikolova Denmark 27 875 1.2× 576 1.1× 1.1k 2.2× 204 0.5× 303 0.7× 60 5.2k
Kyoung‐Ah Kim South Korea 35 1.1k 1.5× 432 0.8× 285 0.6× 248 0.6× 448 1.0× 122 3.7k
David Foster Australia 31 1.2k 1.7× 369 0.7× 361 0.7× 177 0.4× 356 0.8× 109 4.0k
Kazuko Nakagawa Japan 32 588 0.8× 454 0.8× 289 0.6× 152 0.3× 339 0.8× 117 2.8k
Yifei Zhang China 33 1.5k 2.2× 487 0.9× 745 1.5× 202 0.5× 1.1k 2.5× 172 4.0k
Roger Tavendale United Kingdom 27 561 0.8× 517 1.0× 207 0.4× 507 1.2× 493 1.1× 61 3.1k
Donald A. Wiebe United States 29 463 0.7× 487 0.9× 283 0.6× 679 1.5× 752 1.7× 67 3.8k
Tandi E. Matsha South Africa 28 726 1.0× 309 0.6× 522 1.0× 287 0.7× 641 1.5× 143 3.0k
Jason L. Vassy United States 31 791 1.1× 527 1.0× 312 0.6× 1.2k 2.7× 1.2k 2.7× 90 3.7k

Countries citing papers authored by Robert J. Straka

Since Specialization
Citations

This map shows the geographic impact of Robert J. Straka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Straka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Straka more than expected).

Fields of papers citing papers by Robert J. Straka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Straka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Straka. The network helps show where Robert J. Straka may publish in the future.

Co-authorship network of co-authors of Robert J. Straka

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Straka. A scholar is included among the top collaborators of Robert J. Straka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Straka. Robert J. Straka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gaedigk, Andrea, et al.. (2022). The Identification of Novel CYP2D6 Variants in US Hmong: Results From Genome Sequencing and Clinical Genotyping. Frontiers in Pharmacology. 13. 867331–867331. 6 indexed citations
3.
Culhane‐Pera, Kathleen A., et al.. (2020). Differences in Predicted Warfarin Dosing Requirements Between Hmong and East Asians Using Genotype‐Based Dosing Algorithms. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(3). 265–276. 7 indexed citations
4.
Liu, Yuwei, Caren E. Smith, Laurence D. Parnell, et al.. (2020). Salivary AMY1 Copy Number Variation Modifies Age-Related Type 2 Diabetes Risk. Clinical Chemistry. 66(5). 718–726. 9 indexed citations
5.
Holzer, Katherine J., Kathleen A. Culhane‐Pera, Robert J. Straka, et al.. (2020). Hmong participants’ reactions to return of individual and community pharmacogenetic research results: “A positive light for our community”. Journal of Community Genetics. 12(1). 53–65. 13 indexed citations
6.
Culhane‐Pera, Kathleen A., Bharat Thyagarajan, Jeffrey R. Bishop, et al.. (2019). Potential Clinical Relevance of Differences in Allele Frequencies Found within Very Important Pharmacogenes between Hmong and East Asian Populations. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(2). 142–152. 12 indexed citations
7.
An, Ping, Robert J. Straka, Toni I. Pollin, et al.. (2014). Genome-wide association studies identified novel loci for non-high-density lipoprotein cholesterol and its postprandial lipemic response. Human Genetics. 133(7). 919–930. 8 indexed citations
8.
Aslibekyan, Stella, Edmond K. Kabagambe, Marguerite R. Irvin, et al.. (2012). A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network. Pharmacogenetics and Genomics. 22(3). 191–197. 49 indexed citations
9.
Junyent, Mireia, Laurence D. Parnell, Chao‐Qiang Lai, et al.. (2009). Novel variants at KCTD10, MVK, and MMAB genes interact with dietary carbohydrates to modulate HDL-cholesterol concentrations in the Genetics of Lipid Lowering Drugs and Diet Network Study. American Journal of Clinical Nutrition. 90(3). 686–694. 28 indexed citations
10.
Junyent, Mireia, Donna K. Arnett, Michael Y. Tsai, et al.. (2009). Genetic Variants at the PDZ-Interacting Domain of the Scavenger Receptor Class B Type I Interact with Diet to Influence the Risk of Metabolic Syndrome in Obese Men and Women. Journal of Nutrition. 139(5). 842–848. 16 indexed citations
11.
Pérez‐Martínez, Pablo, Nikos Yiannakouris, José López‐Miranda, et al.. (2008). Postprandial triacylglycerol metabolism is modified by the presence of genetic variation at the perilipin (PLIN) locus in 2 white populations. American Journal of Clinical Nutrition. 87(3). 744–752. 26 indexed citations
12.
Smith, Jennifer A., Donna K. Arnett, Reagan Kelly, et al.. (2008). The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment. European Journal of Human Genetics. 16(5). 603–613. 29 indexed citations
13.
Shen, Jian, Donna K. Arnett, Pablo Pérez‐Martínez, et al.. (2008). The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN study*. Journal of Lipid Research. 49(8). 1839–1845. 20 indexed citations
14.
Straka, Robert J., et al.. (2006). Mixture Models and Subpopulation Classification: A Pharmacokinetic Simulation Study and Application to Metoprolol CYP2D6 Phenotype. Journal of Pharmacokinetics and Pharmacodynamics. 34(2). 141–156. 15 indexed citations
15.
Tsai, Michael Y., Naomi Q. Hanson, Robert J. Straka, et al.. (2005). Effect of influenza vaccine on markers of inflammation and lipid profile. Journal of Laboratory and Clinical Medicine. 145(6). 323–327. 78 indexed citations
16.
Straka, Robert J., et al.. (2001). Assessment of Hypercholesterolemia Control in a Managed Care Organization. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(7). 818–827. 45 indexed citations
17.
Straka, Robert J., et al.. (1997). Patient Self‐Reporting of Compliance Does Not Correspond with Electronic Monitoring: An Evaluation Using Isosorbide Dinitrate as a Model Drug. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(1). 126–132. 111 indexed citations
18.
Guay, David R.P., et al.. (1996). QTc‐Interval Prolongation Associated with Slow Intravenous Erythromycin Lactobionate Infusions in Critically Ill Patients: A Prospective Evaluation and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(4). 663–674. 33 indexed citations
19.
Straka, Robert J., et al.. (1990). Analysis of metoprolol enantiomers in human serum by liquid chromatography on a cellulose-based chiral stationary phase. Journal of Chromatography B Biomedical Sciences and Applications. 530(1). 83–93. 24 indexed citations
20.
Lalonde, Richard L., Robert J. Straka, John A. Pieper, Michael B. Bottorff, & David M. Mirvis. (1987). Propranolol pharmacodynamic modeling using unbound and total concentrations in healthy volunteers. Journal of Pharmacokinetics and Biopharmaceutics. 15(6). 569–582. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026